2026-06-29T09:29:08Zhttps://docta.ucm.es/rest/oai/request

oai:docta.ucm.es:20.500.14352/1169002025-03-18T12:42:39Zcom_20.500.14352_14col_20.500.14352_15

00925njm 22002777a 4500 dc San Miguel-Rodríguez, Angel author Armentia, A author Martín Armentia, S author Corell, A author Lozano Estevan, María Del Carmen author Iglesias Peinado, Irene author 2019 Component resolved diagnosis (CRD) is a microarray-based diagnostic solution capable of simultaneously analysing specific IgE antibodies against 112 allergenic components, providing sensitivity patterns for multisensitised or complex patients. The CRD is indicated for these patients, especially those with concomitant respiratory and food allergies. This study reivews the method, its utility, limitations, and our experience in allergic diseases with difficult etiologic diagnosis (eosinophilic esophagitis, occupational asthma and drug allergy). San Miguel-Rodríguez A, Armentia A, Martín-Armentia S, Martín-Armentia B, Corell A, Lozano-Estevan MC, et al. Component-resolved diagnosis in allergic disease: Utility and limitations. Clinica Chimica Acta [Internet]. febrero de 2019 [citado 29 de enero de 2025];489:219-24. Disponible en: https://linkinghub.elsevier.com/retrieve/pii/S0009898118303978 10.1016/J.CCA.2018.08.004 https://hdl.handle.net/20.500.14352/116900 https://doi.org/10.1016/j.cca.2018.08.004 Component-resolved diagnosis in allergic disease: Utility and limitations